ST Pharm Co Ltd
KOSDAQ:237690
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
67 300
132 100
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ST Pharm Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 124 900 KRW, ST Pharm Co Ltd is hidden .
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
ST Pharm Co Ltd
ST Pharm Co Ltd looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether ST Pharm Co Ltd usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for ST Pharm Co Ltd.
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
|
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
ST Pharm Co Ltd
Balance Sheet Decomposition
ST Pharm Co Ltd
| Current Assets | 330.1B |
| Cash & Short-Term Investments | 120.9B |
| Receivables | 70B |
| Other Current Assets | 139.2B |
| Non-Current Assets | 391.8B |
| Long-Term Investments | 23.4B |
| PP&E | 338.7B |
| Intangibles | 16.5B |
| Other Non-Current Assets | 13.2B |
| Current Liabilities | 133.3B |
| Accounts Payable | 10.6B |
| Accrued Liabilities | 1.6B |
| Short-Term Debt | 30B |
| Other Current Liabilities | 91B |
| Non-Current Liabilities | 85.5B |
| Long-Term Debt | 44.8B |
| Other Non-Current Liabilities | 40.7B |
Free Cash Flow Analysis
ST Pharm Co Ltd
| KRW | |
| Free Cash Flow | KRW |
Earnings Waterfall
ST Pharm Co Ltd
|
Revenue
|
298.1B
KRW
|
|
Cost of Revenue
|
-185B
KRW
|
|
Gross Profit
|
113.2B
KRW
|
|
Operating Expenses
|
-70.3B
KRW
|
|
Operating Income
|
42.8B
KRW
|
|
Other Expenses
|
-8.9B
KRW
|
|
Net Income
|
33.9B
KRW
|
Profitability Score
Profitability Due Diligence
ST Pharm Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
ST Pharm Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
ST Pharm Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
ST Pharm Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
ST Pharm Co Ltd
According to Wall Street analysts, the average 1-year price target for ST Pharm Co Ltd is 133 705 KRW with a low forecast of 101 000 KRW and a high forecast of 168 000 KRW.
Dividends
Current shareholder yield for ST Pharm Co Ltd is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one ST Pharm Co Ltd stock under the Base Case scenario is hidden KRW.
Compared to the current market price of 124 900 KRW, ST Pharm Co Ltd is hidden .